Exploring Health Disparities in Childhood Epilepsy

July 3rd, 2023|Categories: Featured, Industry News|Tags: , , , , |

A recently published article in Clinical Psychology in Medical Settings finds that health disparities faced by children and youth with epilepsy (CYE) are poorly explored in the scientific literature. The authors of the paper noted that very few epilepsy studies actually focused on identifying health disparities, with even fewer focusing on CYE.

UK CMA Fines Pfizer and Flynn Pharma £70M in Epilepsy Drug Pricing Case

July 25th, 2022|Categories: Featured, Industry News|Tags: , , , , |

The United Kingdom’s Competition and Markets Authority (CMA) has issued a preliminary judgment fining Pfizer and Flynn Pharma £70 million for abusing their status as the UK’s only suppliers of the epilepsy drug phenytoin. Pfizer and Flynn jacked up the prices of the life-saving drug between 780% and 2,600%, a move deemed by the courts as anti-competitive and exploitative. Pfizer will pay £63 million and Flynn will pay £6.7 million. 

Go to Top